Related Experiment Video
Updated: May 27, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis
Cinzia Tiloca1, Antonia Ratti, Viviana Pensato
1Department of Neurology and Laboratory of Neuroscience, IRCCS, Istituto Auxologico Italiano, Milan, Italy.
Abstract:
Mutations in valosin-containing protein (VCP) gene, already known to be associated with the multisystemic disorder, inclusion body myopathy with Paget's disease and frontotemporal dementia (IBMPFD), have been recently found also in familial cases of amyotrophic lateral sclerosis (ALS). To further define the frequency of VCP mutations in ALS Italian population, we screened a cohort of 166 familial ALS and 14 ALS-frontotemporal dementia (FTD) individuals. We identified a previously reported synonymous mutation (c.2093A>C; p.Q568Q), 2 intronic variants (c.1749-14C>T; c.2085-3C>T), and 1 nucleotide change (c.2814G>T) in the 3' untranslated region (UTR). Bioinformatical analyses predicted no changes in splicing process or microRNA binding sites. Our results do not confirm a main contribution of VCP gene to familial ALS in the Italian population.
Insights
Valosin-containing protein (VCP) gene mutations are not a primary cause of familial amyotrophic lateral sclerosis (ALS) in the Italian population. This study screened VCP in ALS and ALS-frontotemporal dementia (FTD) patients, finding no significant contribution.
Area of Science:
- Genetics
- Neurodegenerative Diseases
- Molecular Biology
Background:
- Valosin-containing protein (VCP) gene mutations are linked to inclusion body myopathy with Paget's disease and frontotemporal dementia (IBMPFD).
- Recent findings suggest VCP mutations may also occur in familial amyotrophic lateral sclerosis (ALS).
Purpose of the Study:
- To investigate the frequency of VCP gene mutations in the Italian population affected by familial ALS and ALS-frontotemporal dementia (FTD).
Main Methods:
- Screening of 166 familial ALS and 14 ALS-FTD individuals for VCP gene mutations.
- Identification of specific mutations and variants, including a synonymous mutation, intronic variants, and a 3' untranslated region (UTR) nucleotide change.
- Bioinformatical analysis to predict the impact of identified variants on splicing and microRNA binding.
Main Results:
- A previously reported synonymous mutation (c.2093A>C; p.Q568Q) was identified.
- Two intronic variants (c.1749-14C>T; c.2085-3C>T) and a 3' UTR nucleotide change (c.2814G>T) were also found.
- Bioinformatical predictions indicated no significant alterations in splicing or microRNA binding sites.
Conclusions:
- The study did not find evidence supporting a major role of VCP gene mutations in familial ALS within the Italian cohort.
- The identified variants were either previously known or predicted to have no functional impact.
Related Concept Videos
Animal Mitochondrial Genetics
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Alzheimer Disease ll: Pathophysiology
Huntington Disease l: Introduction
Viral Mutations
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

